Serologic investigation and management of an antibody screen negative para‐Bombay phenotype during pregnancy
Transfusion Medicine · 2025
DOI: 10.1111/tme.70000 ↗Kurz gefasst
Fallbericht in der Zeitschrift Transfusion Medicine, 2025. Verfasst von Yaseen Ali Jamal und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Stanford University School of Medicine, Stanford, California, USA. Hauptthemen laut MEDLINE: Isoantibodies, ABO Blood-Group System, Erythrocyte Transfusion. Die Arbeit nennt 15 Literaturangaben.
Abstract (Originalsprache)
Background
Individuals with Bombay and para‐Bombay red blood cell (RBC) phenotypes produce anti‐H antibodies associated with acute haemolytic transfusion reactions. The rarity of compatible donor units creates unique logistical challenges, especially during pregnancy as the onset of labour and fetal distress can occur without warning. Case Report A 24‐year‐old female at 38 weeks gestation presented with breech fetal position and reported anti‐H antibodies. Critically, the in‐house antibody screen was negative by automated solid‐phase red cell adherence (SPRCA), while manual testing subsequently demonstrated anti‐H antibodies. Forward typing with Ulex europaeus lectin confirmed the absence of H‐antigen on RBCs, while Lewis phenotyping and saliva neutralisation revealed H‐antigen in secretions, consistent with the para‐Bombay phenotype. Three frozen Bombay RBC units were obtained from a nationwide search, and four cross‐match compatible non‐Bombay (O‐positive) units were also prepared. An external cephalic version (ECV) was originally planned since vaginal delivery carries lower bleeding risk than caesarean section (CS). However, acknowledging the unpredictability of ECV, the challenge of timing thawed units, and the possibilities of massive haemorrhage versus wasting rare donor blood, an elective CS was ultimately preferred. Delivery was uneventful without transfusion needs.
Conclusion
This case highlights key considerations regarding serologic identification, blood product management, and interdisciplinary clinical decision‐making for patients with Bombay and para‐Bombay phenotypes. First, automated SPRCA testing may provide false negative results for anti‐H antibodies. Second, backup transfusion strategies for para‐Bombay patients may include non‐Bombay RBCs. Finally, the procurement, preparation, and use of rare blood products requires thoughtful deliberation between multiple care providers.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Pathology, Stanford University School of Medicine, Stanford, California, USA.
ORCID-Profile: Yaseen Ali Jamal, Joshua Alston Nicholas, Mohamed Abdelmonem
Zitieren
APA
Jamal, Y. A., Nicholas, J. A., Wang, T., Abdelmonem, M., Pandey, S., & Virk, M. S. (2025). Serologic investigation and management of an antibody screen negative para‐Bombay phenotype during pregnancy. Transfusion Medicine. https://doi.org/10.1111/tme.70000
Vancouver
Jamal YA, Nicholas JA, Wang T, Abdelmonem M, Pandey S, Virk MS. Serologic investigation and management of an antibody screen negative para‐Bombay phenotype during pregnancy. Transfusion Medicine. 2025. doi:10.1111/tme.70000
BibTeX
@article{Jamal2025,
author = {Jamal, Yaseen Ali and Nicholas, Joshua Alston and Wang, Tong and Abdelmonem, Mohamed and Pandey, Suchitra and Virk, Mrigender Singh},
title = {Serologic investigation and management of an antibody screen negative para‐Bombay phenotype during pregnancy},
journal = {Transfusion Medicine},
year = {2025},
doi = {10.1111/tme.70000}
}
EUVIMED